Patents by Inventor Nobuo Kondoh

Nobuo Kondoh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5610169
    Abstract: The orally administrable pharmaceutical compositions containing a slightly water-soluble drug, characterized by improved stability and improved absorption of the drug from digestive tract into blood. The use of the compositions of the present invention enables decrease of the dose amount of a slightly water-soluble drug, which eventually leads to alleviation of pains and side effects on the part of patients.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: March 11, 1997
    Assignee: The Green Cross Corporation
    Inventors: Toru Iwao, Kenichi Hirai, Nobuo Kondoh, Koichi Yamanouchi, Kazumasa Yokoyama
  • Patent number: 5491171
    Abstract: A pharmaceutical preparation for rectal or vaginal administration, comprising a prostaglandin compound and an alkali metal salt of a fatty acid having 8 to 12 carbon atoms, and a method for administering a prostaglandin compound, comprising rectally or vaginally administering same in the presence of an alkali metal salt of a fatty acid.According to the present invention, absorption of prostaglandin from rectum or vagina can be enhanced.The prostaglandin can be stabilized in the preparation.
    Type: Grant
    Filed: July 27, 1994
    Date of Patent: February 13, 1996
    Assignees: Kyoto Pharmaceutical Industries, Ltd., The Green Cross Corporation
    Inventors: Ken-ichi Nishimura, Akihisa Yoshimi, Takayoshi Mori, Nobuharu Kakeya, Masahiro Kikuchi, Nobuo Kondoh, Takeshi Uchida, Koichi Yamanouchi
  • Patent number: 5462951
    Abstract: The orally administrable pharmaceutical compositions containing a slightly water-soluble drug, characterized by improved stability and improved absorption of the drug from digestive tract into blood. The use of the compositions of the present invention enables decrease of the dose amount of a slightly water-soluble drug, which eventually leads to alleviation of pains and side effects on the part of patients.
    Type: Grant
    Filed: September 3, 1993
    Date of Patent: October 31, 1995
    Assignee: The Green Cross Corporation
    Inventors: Toru Iwao, Kenichi Hirai, Nobuo Kondoh, Koichi Yamanouchi, Kazumasa Yokoyama